Stockreport

Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027 [Yahoo! Finance]

Cardiol Therapeutics Inc. - Class A Common Shares  (CRDL) 
PDF New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardio [Read more]